Catalyst Pharmaceuticals (CPRX) Revenue Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 5.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.63% |
| Dec 31, 2025 | 7.61% |
| Sep 30, 2025 | 15.31% |
| Jun 30, 2025 | 19.44% |
| Mar 31, 2025 | 43.56% |
| Dec 31, 2024 | 28.26% |
| Sep 30, 2024 | 25.33% |
| Jun 30, 2024 | 23.23% |
| Mar 31, 2024 | 15.40% |
| Dec 31, 2023 | 81.98% |
| Sep 30, 2023 | 79.39% |
| Jun 30, 2023 | 87.49% |
| Mar 31, 2023 | 98.12% |
| Dec 31, 2022 | 58.60% |
| Sep 30, 2022 | 59.21% |
| Jun 30, 2022 | 46.06% |
| Mar 31, 2022 | 42.66% |
| Dec 31, 2021 | 23.52% |
| Sep 30, 2021 | 22.64% |
| Jun 30, 2021 | 22.83% |
| Mar 31, 2021 | 3.67% |
| Dec 31, 2020 | 2.96% |
| Sep 30, 2020 | -5.12% |
| Jun 30, 2020 | 2.66% |
| Mar 31, 2020 | 134.06% |
| Dec 31, 2019 | 5,924.51% |